Erschienen in:
08.11.2016 | Case Report
Anti-N-methyl-d-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges
verfasst von:
Flora Schein, Amandine Gagneux-Brunon, Jean-Christophe Antoine, Sylvie Lavernhe, Sylvie Pillet, Stéphane Paul, Anne Frésard, Claire Boutet, Rémi Grange, Céline Cazorla, Frédéric Lucht, Elisabeth Botelho-Nevers
Erschienen in:
Infection
|
Ausgabe 4/2017
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Morbidity and mortality of Herpes simplex virus encephalitis (HSE) remain high.
Relapses of neurological signs may occur after initial clinical improvement under acyclovir treatment.
Methods
We report here a case of post-HSE anti-N-methyl-d-aspartate receptor-mediated encephalitis in an adult and perform a systematic search on PubMed to identify other cases in adults.
Results
We identified 11 previously published cases, to discuss diagnostic and therapeutic management.
Symptoms in adults are often inappropriate behaviors, confusion and agitation. Diagnosis of anti-NMDA-R
encephalitis after HSE is often delayed. Treatment consists in steroids, plasma exchange, and rituximab.
Prognosis is often favorable.
Conclusion
Anti-NMDA-R antibodies should be searched in cerebrospinal fluid of patients with unexpected evolution of HSE. This emerging entity reopens the hot debate about steroids in HSE.